Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)
791.50
-15.00 (-1.86%)
At close: Jul 26, 2026
Ambee Pharmaceuticals Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 157.61 | 230.55 | 219.3 | 198.1 | 180.99 | 98.98 |
Revenue Growth | -32.99% | 5.13% | 10.71% | 9.45% | 82.86% | -65.31% |
Gross Profit Gross Profit Growth | 72.95 | 111.39 | 116.16 | 105.56 | 97.37 | 40.71 |
Operating Income Operating Income Growth | 4.06 | 7.39 | 12.41 | 13.17 | 14.86 | -7.28 |
Net Income Net Income Growth | 5.53 | 5.31 | 9.68 | 9.09 | 8.06 | -13.01 |
Earnings Per Share EPS Growth | 2.30 | 2.21 | 4.03 | 3.79 | 3.36 | -5.42 |
EPS Growth | -45.16% | -45.17% | 6.53% | 12.79% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Bangladesh Bangladesh Growth | 147.21 | 220.15 | 219.3 | 195.47 | 180.99 | 98.98 |
Export Export Growth | - | 10.4 | - | 2.62 | - | - |
Total Total Growth | 157.61 | 230.55 | 219.3 | 198.1 | 180.99 | 98.98 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 97.86 | 132.64 | 32.74 | 28.57 | 16.92 | 15.09 |
Total Debt Total Debt Growth | 660.41 | 638.94 | 0.84 | 392.48 | 344.88 | 239.85 |
Net Cash (Debt) Net Cash Growth | -562.54 | -506.3 | 31.9 | -363.91 | -327.96 | -224.75 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -234.39 | -210.96 | 13.29 | -151.63 | -136.65 | -93.65 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -18.41 | 21.73 | -65.92 | -35.23 | -73.18 | -5.45 |
Capital Expenditures CapEx Growth | 0 | -23.79 | -2.2 | -0.11 | -1.53 | - |
Free Cash Flow Free Cash Flow Growth | -18.41 | -2.06 | -68.12 | -35.34 | -74.71 | -5.45 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 46.28% | 48.31% | 52.97% | 53.29% | 53.80% | 41.13% |
Operating Margin | 2.57% | 3.21% | 5.66% | 6.65% | 8.21% | -7.36% |
Pretax Margin | 4.84% | 3.17% | 5.40% | 5.39% | 5.65% | -12.41% |
Profit Margin | 3.51% | 2.30% | 4.42% | 4.59% | 4.45% | -13.14% |
FCF Margin | -11.68% | -0.89% | -31.06% | -17.84% | -41.28% | -5.51% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.000 | 1.500 | 1.000 |
Dividend Per Share Growth | 0% | 0% | -33.33% | 50.00% | - |
Dividend Yield | 0.12% | 0.12% | 0.13% | 0.27% | 0.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 343.67 | 369.08 | 188.91 | 144.98 | 156.37 | - |
PS Ratio | 12.05 | 8.50 | 8.34 | 6.65 | 6.96 | 9.95 |